| Pattern of drug resistance |
New TB |
Previous treated |
Total % |
| No of patients |
151(83.8%) |
29(16.1%) |
180(32.7%) |
| Susceptible drug |
|
|
|
| SIRE |
95(52.7) |
2(1.1%) |
97(53.8%) |
| Mono drug resistance |
23(12.7) |
11(6.1%) |
34(18.8%) |
| S |
6(3.3%) |
2(1.1%) |
8(4.4%) |
| I |
7(3.8%) |
5(2.7%) |
12(6.6%) |
| R |
3(1.6%) |
2(1.1%) |
5(2.7%) |
| E |
7(3.8%) |
2(1.1%) |
9(5%) |
| Multi drug resistance |
6(3.3%) |
8(4.4%) |
14(7.7%) |
| IR |
1(0.5%) |
- |
1(0.5%) |
| SIR |
2(1.1%) |
3(1.6%) |
5(2.7%) |
| EIR |
1(0.5%) |
2(1.1%) |
3(1.6%) |
| SIRE |
2(1.1%) |
3(1.6%) |
5(2.7%) |
| Poly-drug resistance |
27(15%) |
8(4.4%) |
35(19.4%) |
| SIE |
8(4.4%) |
3(1.6%) |
11(6.1%) |
| IE |
11(6.1%) |
3(1.6%) |
14(7.7%) |
| SE |
2(1.1%) |
- |
2(1.1%) |
| SI |
3(1.6%) |
1(0.5%) |
4(2.2%) |
| SR |
3(1.6%) |
1(0.5%) |
4(2.2%) |
| SRE |
- |
- |
- |
| Total drug resistance |
56(31.1%) |
27(15%) |
83(46.1%) |
S: Streptomycin, I: Isoniazid, R: Rifampicin, E: Ethambutol |
